Now partnering with global institutions and investors to scale innovation where it matters most.
Ophiomics is building the world’s first end-to-end Precision Liver Medicine platform, combining AI-powered diagnostics, cloud-based tools, and clinically validated biomarkers for early detection, treatment selection, and disease monitoring.
Related Posts
👏💪 It’s out! Our latest study addresses a critical need in gastroenterology: early and accurate identification of Barrett’s Esophagus (BE)
We’re excited to announce that HepatoPredict, our CE-IVD prognostic tool to assess hepatocellular carcinoma (HCC) recurrence in the context of
HepatoDetect Shows Strong Potential for Early HCC Detection HepatoDetect, our AI-driven liquid biopsy platform designed for the early detection of
Fatty liver disease is a metabolic dysfunction that affects approximately one in every four adults and is particularly common among
+351 211 369 829 